Methods for treating HCV

• 收藏
• 分享

专利权人:

AbbVie Inc.

发明人:

COLLINS, Christine,FU, Bo,GULATI, Abhishek,KORT, Jens,KOSLOSKI, Matthew,LEI, Yang,LIN, Chih-Wei,LIU, Ran,MENSA, Federico,NG, Iok Chan,PILOT-MATIAS, Tami,PUGATCH, David,SHULMAN, Nancy S.,TRINH, Roger,V

申请号：

AU2018311684

公开号：

AU2018311684A1

申请日:

2018.07.20

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/